SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cambridge Antibody Technology Group
An SI Board Since December 1999
Posts SubjectMarks Bans
625 23 0
Emcee:  Jongmans Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
425<i>Now before the High Court</i>. This is great news.keokalani'nui-11/17/2003
424<i>Some comment on the Humira litigation:</i> UPDATE - UK's CATnigel bates-11/17/2003
423CAT results (too long to try posting for now): biz.yahoo.com Humira dispute gonenigel bates-11/17/2003
422United States Patent Application 20020076692 Kind Code A1 Osbourn, Jane ; nigel bates-11/6/2003
421Not sloppy. ABT may be pointing at competing phage IP, target IP, formulation Ikeokalani'nui-10/21/2003
420<i>Abbott has sought to offset royalties payable to other licensor<b>nigel bates-10/21/2003
419No kidding. Still, with the GENZ cash (which is in itself quite enough in the wnigel bates-10/15/2003
418S3/A. $175mm shelf, at these prices? Horrifying.keokalani'nui-10/15/2003
417As for royalty #'s I don't know the answer. I'm using 3% net to CATkeokalani'nui-10/15/2003
416Comment from the FT. (What are the royalty numbers ? Every time I see an estimanigel bates-10/15/2003
415BREEACH!!!! Cambridge Antibody Technology Receives First Payment of HUMIRA(R) Rkeokalani'nui-10/14/2003
414This is the month ABT decides whether to breach the contract.keokalani'nui-10/9/2003
413From a Reuters story regarding Abbott's earnings call announcement today: &tuck-10/9/2003
412Abbott Laboratories Expands HUMIRA(R) (adalimumab) Clinical Trial Program In Psonigel bates-10/7/2003
411Abbott Laboratories Expands HUMIRA(R) (adalimumab) Clinical Trial Program In Cronigel bates-9/29/2003
410Slightly OT, but the GENZ deal circular reminded me of something that has annoyenigel bates-9/27/2003
409Has Genzyme or anyone ever done anything with these -- other than buying them frmopgcw-9/22/2003
408The Celltrix (Insmed) TGF beta patents: 1 5,783,185 Monoclonal antibodies to trnigel bates-9/22/2003
407Got around to having a look at the agreement with GENZ. It appears (from memory,nigel bates-9/22/2003
406neither do i , sold my position too early again ;-) Cheers Stefaandalroi-9/22/2003
405I can't figure DYAX now, either (I have them in my 2003 contest, but no longnigel bates-9/22/2003
404Nigel still strange but Dyax is up in this market where is the fish ???? cheedalroi-9/22/2003
403IMO, the most dyax could have received was nice, but nearly immaterial to CAT. keokalani'nui-9/22/2003
402I'm guessing that their claim to royalties was legally dubious, and that thenigel bates-9/22/2003
401Reuters report which seems to draw the same conclusions. (One other thing that nigel bates-9/22/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News